Related Experiment Videos

Gene therapy for the lysosomal storage disorders.

Mario A Cabrera-Salazar1, Enrico Novelli, John A Barranger

  • 1Department of Human Genetics, University of Pittsburgh, PA 15261, USA.

Current Opinion in Molecular Therapeutics
|September 12, 2002
PubMed
Summary

Gene therapy offers a promising alternative for lysosomal storage disorders (LSDs), particularly for neurological symptoms unresponsive to current treatments like enzyme replacement therapy (ERT). This review explores gene therapy strategies for LSDs, including those for Gaucher disease Type 1.

Related Concept Videos